TY - CHAP A1 - Ibrahim Omerhodžić A2 - Almir Džurlić A3 - Adi Ahmetspahić A4 - Bekir Rovčanin A5 - Mirela Kalamujić A6 - Nurija Bilalović A7 - Bilal Imširović A8 - Enra Suljić ED1 - Ibrahim Omerhodžić ED2 - Kenan Arnautović Y1 - 2019-01-16 PY - 2019 T1 - Neurosurgical Options for Glioma N2 - The past three decades have been marked with huge enthusiasm from scientists and professionals in an effort to find a cure for glioma disease. Methods to confirm the kinds and grades of glioma have taken a path from classical macro- to microscopic pathohystological confirmation of tumors, through morphological-histological, molecular, and genetic diagnosis. Surgically, progress was made possible with the development and use of technological aids, for example neuronavigation, cortical mapping, electrocorticography, neuromonitoring, functional and intraoperative MRI, magnetoencephalography, etc. Great hope was placed on the extension of tumor resection and popular supratotal resection. Significant progress has been made generally in glioma treatment with the use of modern radiotherapy and new chemotherapeutics. What do we want to see for the future? By way of stem cells, a specific medicine will be produced, individualized for the particular patient, and by using a microcapsule it will be implanted into the brain zone affected by the tumor by way of robot surgery and injection needle. This is not at all an unrealistic expectation in the next decade or two. BT - Glioma SP - Ch. 7 UR - https://doi.org/10.5772/intechopen.82603 DO - 10.5772/intechopen.82603 SN - 978-1-78984-954-7 PB - IntechOpen CY - Rijeka Y2 - 2020-03-29 ER -